Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313

European Journal of Pharmacology
G CheymolH Schmitt

Abstract

No abstract listed.

References

Jun 1, 1973·European Journal of Pharmacology·B Delbarre, H Schmitt
Feb 1, 1974·European Journal of Pharmacology·K R AdamJ Linnell
Feb 1, 1976·European Journal of Pharmacology·P MouilléE Gauter
Feb 1, 1974·British Journal of Clinical Pharmacology·J M Ekue, R G Shanks
Jan 1, 1987·The Journal of Pharmacy and Pharmacology·L M Plunkett, R L Tackett

Citations

Dec 1, 1965·British Journal of Pharmacology and Chemotherapy·J W BlackR G Shanks
Jan 1, 1968·British Journal of Pharmacology and Chemotherapy·D Dunlop, R G Shanks
Dec 1, 1968·The Journal of Pharmacy and Pharmacology·M D DayP R Warren
Aug 1, 1968·European Journal of Pharmacology·C Raper, J Wale
Nov 1, 1953·Proceedings of the Society for Experimental Biology and Medicine·K J BONIFACER P WALTON
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Jun 1, 1963·Circulation Research·J H SIEGEL, E H SONNENBLICK
Feb 1, 1965·The Journal of Pharmacology and Experimental Therapeutics·P SOMANI, B K LUM
Apr 1, 1965·British Journal of Pharmacology and Chemotherapy·A MORALES AGUILERA, E M VAUGHANWILLIAMS

Related Concepts

Coronary Circulation
Airway Resistance
Diastolic Blood Pressure
Salientia
Norepinephrine, (+, -)-Isomer
Right Atrial Structure
Amino Alcohols
Topical anesthetic
Propylamines
Pulmonary Vascular Resistance

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.